Acute Respiratory Distress Syndrome (ARDS)
100 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the acceptable PF ratio range for mild ARDS?

  • 300 to 400
  • 100 to 200
  • Less than 100
  • 200 to 300 (correct)

    • Cyanosis can occur due to significantly high blood oxygen levels.

    False

    What are the primary imaging techniques used to diagnose ARDS?

    Chest X-ray, CT Scans, Lung Ultrasound

    The PF ratio is calculated by dividing the arterial partial pressure of oxygen (PaO2) by the fraction of inspired _______.

    <p>oxygen</p> Signup and view all the answers

    Which of the following is a treatment approach for moderate to severe ARDS?

    <p>Immediate intubation</p> Signup and view all the answers

    Match the following ARDS classifications with their PF ratio ranges:

    <p>Mild ARDS = 200-300 Moderate ARDS = 100-200 Severe ARDS = Less than 100</p> Signup and view all the answers

    PEEP is used to prevent the collapse of fluid-filled or consolidated alveoli during ventilation.

    <p>True</p> Signup and view all the answers

    What role do Type 2 pneumocytes play in the resolution of ARDS?

    <p>Surfactant production and fluid removal</p> Signup and view all the answers

    A normal PF ratio is considered to be above ______.

    <p>300</p> Signup and view all the answers

    Which therapy is commonly associated with non-invasive positive pressure ventilation?

    <p>BiPAP</p> Signup and view all the answers

    What is the most common cause of Acute Respiratory Distress Syndrome (ARDS)?

    <p>Pneumonia</p> Signup and view all the answers

    ARDS typically develops over a period of weeks.

    <p>False</p> Signup and view all the answers

    What imaging finding is characteristic of ARDS?

    <p>Bilateral opacification on chest X-ray</p> Signup and view all the answers

    Patients with ARDS may experience ______, ______, and possible cyanosis.

    <p>dyspnea, hypoxemia</p> Signup and view all the answers

    Match the causes of ARDS with their descriptions:

    <p>Sepsis = Triggers a cytokine storm increasing pulmonary capillary permeability Aspiration Pneumonia = Damage from acidic substances due to aspiration of gastric contents Pneumonia = Caused by pathogens such as Streptococcus pneumoniae Transfusion-Related Acute Lung Injury (TRALI) = Caused by antibodies in transfusion products</p> Signup and view all the answers

    What effect does fresh water drowning have on the lungs?

    <p>Washes surfactant away</p> Signup and view all the answers

    Cyanosis is a common symptom of ARDS.

    <p>True</p> Signup and view all the answers

    Name one common pathogen responsible for pneumonia leading to ARDS.

    <p>Streptococcus pneumoniae</p> Signup and view all the answers

    In ARDS, activated alveolar macrophages release ______ causing increased capillary permeability.

    <p>cytokines</p> Signup and view all the answers

    What is a possible consequence of injury to Type 1 and Type 2 pneumocytes in ARDS?

    <p>Impaired gas exchange</p> Signup and view all the answers

    What is the most common indirect cause of Acute Respiratory Distress Syndrome (ARDS)?

    <p>Sepsis</p> Signup and view all the answers

    Aspiration pneumonia can lead to ARDS due to damage caused by acidic substances.

    <p>True</p> Signup and view all the answers

    Name a common pathogen associated with pneumonia leading to ARDS.

    <p>Streptococcus pneumoniae</p> Signup and view all the answers

    In cases of near drowning, __________ causes hypotonic fluid effects, washing away surfactant.

    <p>freshwater</p> Signup and view all the answers

    Match the causes of ARDS with their descriptions:

    <p>Pneumonia = Most common direct cause of ARDS Sepsis = Most common indirect cause of ARDS Toxic Smoke Inhalation = Direct damage to alveolar cells Fat Emboli = Long bone fractures releasing fat globules</p> Signup and view all the answers

    Which of the following is NOT a direct lung injury leading to ARDS?

    <p>Sepsis</p> Signup and view all the answers

    Cyanosis is a common symptom of ARDS.

    <p>True</p> Signup and view all the answers

    What is the role of activated alveolar macrophages in ARDS?

    <p>They release cytokines causing increased capillary permeability.</p> Signup and view all the answers

    In ARDS, injury to Type 1 and Type 2 pneumocytes results in impaired __________.

    <p>gas exchange</p> Signup and view all the answers

    Which of the following best describes the imaging characteristic of ARDS on a chest X-ray?

    <p>Bilateral opacification</p> Signup and view all the answers

    What is a common reflex response to hypoxemia in patients with ARDS?

    <p>Increased respiratory rate</p> Signup and view all the answers

    Cyanosis is an indication of significantly low blood oxygen levels in ARDS patients.

    <p>True</p> Signup and view all the answers

    What does the acronym NIPPV stand for?

    <p>Non-invasive positive pressure ventilation</p> Signup and view all the answers

    The presence of a ________ membrane in ARDS impedes gas exchange.

    <p>hyaline</p> Signup and view all the answers

    Match the PF ratio classifications with their meanings:

    <p>200 to 300 = Mild ARDS 100 to 200 = Moderate ARDS Less than 100 = Severe ARDS Above 300 = Normal</p> Signup and view all the answers

    Which imaging technique is primarily used to diagnose ARDS?

    <p>Chest X-ray</p> Signup and view all the answers

    Higher tidal volumes can be beneficial in ARDS management to reduce mortality risk.

    <p>False</p> Signup and view all the answers

    What is the role of PEEP in ARDS management?

    <p>It maintains open alveoli during ventilation.</p> Signup and view all the answers

    The Berlin Criteria requires exclusion of ________ causes for pulmonary edema in ARDS diagnosis.

    <p>cardiogenic</p> Signup and view all the answers

    Which therapy is often indicated for managing severe ARDS?

    <p>Immediate intubation</p> Signup and view all the answers

    Which of these statements about the PF ratio in ARDS is correct?

    <p>A PF ratio above 300 indicates normal oxygenation</p> Signup and view all the answers

    A major symptom of ARDS is the presence of crackles on auscultation due to fluid accumulation.

    <p>True</p> Signup and view all the answers

    What is the primary imaging technique used to diagnose ARDS?

    <p>Chest X-ray</p> Signup and view all the answers

    In ARDS, a significant reflex response to hypoxemia includes an increased ________ rate.

    <p>respiratory</p> Signup and view all the answers

    Match the following ARDS classifications with their PF ratio ranges:

    <p>Mild ARDS = 200 to 300 Moderate ARDS = 100 to 200 Severe ARDS = Less than 100 Normal PF ratio = Above 300</p> Signup and view all the answers

    What is a commonly used method for delivering high flow oxygen in ARDS management?

    <p>High Flow Nasal Cannula</p> Signup and view all the answers

    Proning is a treatment strategy that can improve ventilation and oxygenation in ARDS patients.

    <p>True</p> Signup and view all the answers

    What condition is indicated by a ‘crazy paving’ pattern on imaging in severe ARDS cases?

    <p>Extensive consolidation</p> Signup and view all the answers

    The Swan-Ganz catheter measures pulmonary capillary wedge pressure, helping to indicate ________ pulmonary edema.

    <p>non-cardiogenic</p> Signup and view all the answers

    Which treatment is essential for maintaining open alveoli in patients with ARDS?

    <p>Positive End Expiratory Pressure (PEEP)</p> Signup and view all the answers

    Which of the following is a direct lung injury associated with ARDS?

    <p>Pneumonia</p> Signup and view all the answers

    Toxic smoke inhalation results in the direct damage of alveolar cells.

    <p>True</p> Signup and view all the answers

    Name one cytokine released by activated alveolar macrophages in ARDS.

    <p>IL-1</p> Signup and view all the answers

    The most common indirect cause of ARDS is __________.

    <p>sepsis</p> Signup and view all the answers

    Match the following causes of ARDS to their brief descriptions:

    <p>Aspiration Pneumonia = Damage caused by acidic substances Fat Emboli = Fat globules released from long bone fractures Pneumonia = Infection leading to lung inflammation Transfusion-Related Acute Lung Injury (TRALI) = Neutrophil activation due to antibodies in transfusions</p> Signup and view all the answers

    Which imaging finding is commonly associated with ARDS?

    <p>Bilateral opacification</p> Signup and view all the answers

    Near drowning in freshwater leads to hypertonic effects in the lungs.

    <p>False</p> Signup and view all the answers

    What is the primary effect of injury to Type 1 and Type 2 pneumocytes in ARDS?

    <p>Impaired gas exchange</p> Signup and view all the answers

    The presence of __________ in ARDS impedes gas exchange.

    <p>edema</p> Signup and view all the answers

    Which of the following is a common pathogen associated with pneumonia leading to ARDS?

    <p>Streptococcus pneumoniae</p> Signup and view all the answers

    What is the main function of Type 2 pneumocytes in lung tissue?

    <p>Surfactant production and fluid removal</p> Signup and view all the answers

    A PF ratio above 300 indicates mild ARDS.

    <p>False</p> Signup and view all the answers

    What imaging finding is common in severe ARDS cases?

    <p>Crazy paving pattern</p> Signup and view all the answers

    In ARDS, increased respiratory rate is known as ________.

    <p>tachypnea</p> Signup and view all the answers

    Match the following types of ARDS with their PF ratio classifications:

    <p>Mild ARDS = 200 to 300 Moderate ARDS = 100 to 200 Severe ARDS = Less than 100 Normal condition = Above 300</p> Signup and view all the answers

    What is one of the main treatments for moderate to severe ARDS?

    <p>Immediate intubation and lung protective ventilation</p> Signup and view all the answers

    PEEP is used primarily to increase the risk of alveolar collapse during exhalation.

    <p>False</p> Signup and view all the answers

    What is the term for the non-invasive positive pressure ventilation commonly used in ARDS management?

    <p>NIPPV</p> Signup and view all the answers

    What does a decrease in the PF ratio primarily indicate in ARDS?

    <p>Impaired oxygenation</p> Signup and view all the answers

    The standard PEEP level targeted during ventilation in ARDS management is greater than ______ cm H2O.

    <p>5</p> Signup and view all the answers

    What is the most common cause of ARDS associated with direct lung injury?

    <p>Pneumonia</p> Signup and view all the answers

    Aspiration of gastric contents can potentially lead to ARDS.

    <p>True</p> Signup and view all the answers

    Name one common pathogen that can cause pneumonia leading to ARDS.

    <p>Streptococcus pneumoniae</p> Signup and view all the answers

    In ARDS, activated alveolar macrophages release ______ that increase capillary permeability.

    <p>cytokines</p> Signup and view all the answers

    Match the following causes of ARDS with their descriptions:

    <p>Pneumonia = Most common direct lung injury Sepsis = Most common overall cause of ARDS Transfusion-Related Acute Lung Injury = Caused by antibodies in transfusion products Near Drowning = Freshwater induces hypotonic effects</p> Signup and view all the answers

    Which imaging finding is indicative of ARDS on a chest X-ray?

    <p>Bilateral opacification</p> Signup and view all the answers

    Sepsis is not an indirect cause of ARDS.

    <p>False</p> Signup and view all the answers

    Injury to Type 1 and Type 2 pneumocytes in ARDS leads to impaired ______ exchange.

    <p>gas</p> Signup and view all the answers

    What mechanism does fresh water drowning have on the lungs?

    <p>Washes away surfactant</p> Signup and view all the answers

    Which of the following is a direct lung injury from trauma?

    <p>Lung contusions</p> Signup and view all the answers

    What does ARDS primarily manifest as?

    <p>Respiratory failure with dyspnea and hypoxemia</p> Signup and view all the answers

    Sepsis is considered a direct lung injury cause of ARDS.

    <p>False</p> Signup and view all the answers

    Name one common pathogen associated with aspiration pneumonia leading to ARDS.

    <p>Streptococcus pneumoniae</p> Signup and view all the answers

    In cases of near drowning, _____ creates a hypertonic environment that leads to pulmonary edema.

    <p>saltwater</p> Signup and view all the answers

    Match the direct lung injury causes to their descriptions:

    <p>Pneumonia = Most common cause of ARDS Aspiration Pneumonia = Damage due to acidic substances Lung Contusions = Injury from trauma affecting lung parenchyma Toxic Smoke Inhalation = Direct damage to alveolar cells</p> Signup and view all the answers

    Which of the following is a common symptom of ARDS?

    <p>Dyspnea</p> Signup and view all the answers

    Activated alveolar macrophages release cytokines that reduce capillary permeability.

    <p>False</p> Signup and view all the answers

    What is the primary pathophysiological change in ARDS that affects gas exchange?

    <p>Injury to Type 1 and Type 2 pneumocytes</p> Signup and view all the answers

    Fat emboli can originate from ______ that release fat globules into circulation.

    <p>long bone fractures</p> Signup and view all the answers

    Match the indirect lung injury causes of ARDS with their descriptions:

    <p>Sepsis = Common overall cause of ARDS Pancreatitis = Inflammation releases damaging enzymes Fat Emboli = Long bone fractures leading to fatty damage Drug Toxicity = Includes substances like cocaine and opioids</p> Signup and view all the answers

    What is the primary goal of lung protective ventilation strategies in ARDS management?

    <p>Minimize further lung injury by using lower tidal volumes</p> Signup and view all the answers

    A PF ratio of 150 indicates mild ARDS.

    <p>False</p> Signup and view all the answers

    What is a common imaging finding in ARDS when using a chest X-ray?

    <p>Bilateral opacification</p> Signup and view all the answers

    To avoid hyperoxia, aim for a fraction of inspired oxygen (FiO2) levels of _______ or lower.

    <p>60%</p> Signup and view all the answers

    Match the following ARDS management strategies with their descriptions:

    <p>NIPPV = Non-invasive positive pressure ventilation PEEP = Preventing alveolar collapse during exhalation BiPAP = Bilevel positive airway pressure for inspiratory and expiratory assistance ECMO = Extracorporeal membrane oxygenation for refractory cases</p> Signup and view all the answers

    What reflex action occurs in response to hypoxemia?

    <p>Increased heart rate</p> Signup and view all the answers

    The presence of 'crazy paving' patterns on imaging is a sign of mild ARDS.

    <p>False</p> Signup and view all the answers

    What is the role of Type 2 pneumocytes in the resolution of ARDS?

    <p>Surfactant production and fluid removal</p> Signup and view all the answers

    To assess the severity of ARDS, the PF ratio is calculated using PaO2 divided by _______.

    <p>FiO2</p> Signup and view all the answers

    What is the main purpose of calling for early intubation in moderate to severe ARDS?

    <p>To provide adequate ventilation and oxygenation</p> Signup and view all the answers

    Study Notes

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS is characterized by respiratory failure, notably dyspnea, hypoxemia, and possible cyanosis, usually developing acutely within a week of an initial insult.
    • Imaging shows bilateral opacification ("white out") on chest X-ray.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia: Most common cause (bacterial, viral, fungal). Common pathogens include Streptococcus pneumoniae, Staphylococcus aureus, and PJP (especially in immunocompromised patients).
      • Aspiration Pneumonia: Aspiration of gastric contents causes damage due to acidic substances.
      • Lung Contusions: Trauma leading to contusions impacts lung parenchyma directly.
      • Near Drowning:
        • Freshwater causes hypotonic fluid effects, washing surfactant away, while saltwater creates a hypertonic environment leading to pulmonary edema.
      • Toxic Smoke Inhalation: Directly damages alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis: The most common overall cause. Triggers a cytokine storm leading to increased permeability of pulmonary capillaries and results in fluid leakage into alveoli.
      • Pancreatitis: Inflammation releases various enzymes and cytokines that damage alveolar and capillary endothelia.
      • Fat Emboli: Long bone fractures release fat globules that lead to oleic acid production, damaging alveolar and capillary integrity.
      • Transfusion-Related Acute Lung Injury (TRALI): Occurs due to antibodies present in transfusion products stimulating neutrophil activation, causing endothelial damage.
      • Drug Toxicity: Includes cocaine, opioids, and aspirin toxicity; mechanisms largely unclear.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes leads to both impaired gas exchange and reduced surfactant production.

    • Activated alveolar macrophages release cytokines (IL-1, IL-6, TNF-alpha) causing:

      • Increased capillary permeability → fluid extravasation.
      • Recruitment of neutrophils, which release reactive oxygen species and proteases, further damaging alveolar cells.

    • The combination of fluid, cellular debris, proteins, and red blood cells forms a hyaline membrane, impeding gas exchange and resulting in hypoxemia.

    • Reflex actions to hypoxemia include:

      • Increased respiratory rate (tachypnea) and heart rate (tachycardia).
      • Cyanosis may occur due to significantly low blood oxygen levels.

    Diagnosis of ARDS

    • Berlin Criteria:

      • Symptoms of acute respiratory failure within one week of an insult.
      • Bilateral opacification observable on imaging (X-ray, CT, or lung ultrasound).
      • Non-cardiogenic origin of pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray: Primary tool, showing bilateral white out or opacification.
      • CT Scans: Offer detailed visualization of lung conditions, identifying consolidation and edema.
      • Lung Ultrasound: Fast bedside assessment, identifying B lines indicative of pulmonary edema.

    Clinical Manifestations

    • Symptoms include severe respiratory distress, crackles on auscultation due to fluid in interstitial and alveolar spaces.
    • Severe cases may show a “crazy paving” pattern on imaging due to extensive consolidation.

    Potential Outcomes

    • Resolution can lead to re-epithelialization and repair of lung tissues; Type 2 pneumocytes play a critical role in surfactant production and fluid removal.
    • Severe cases may result in fibrotic lung parenchyma, leading to long-term complications like restrictive lung disease and persistent hypoxemia.### PF Ratio and ARDS Diagnosis
    • PF ratio is calculated by dividing the arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • A normal PF ratio is above 300; values below this indicate varying degrees of ARDS severity.
    • PF ratio classifications:
      • Mild ARDS: 200 to 300
      • Moderate ARDS: 100 to 200
      • Severe ARDS: less than 100
    • Example calculations:
      • Normal condition: PaO2 of 100 mmHg with FiO2 of 0.21 results in a PF ratio of 476.
      • Mild ARDS scenario: PaO2 of 100 mmHg with FiO2 of 0.4 results in a PF ratio of 250.
      • Moderate ARDS: PaO2 of 100 mmHg with FiO2 of 0.6 leads to a PF ratio of 166.
      • Severe ARDS: PaO2 of 90 mmHg with FiO2 of 1.0 results in a PF ratio of 90.

    Berlin Criteria for ARDS

    • The Berlin criteria define ARDS with attributes like:
      • Abnormal chest X-ray showing bilateral opacities.
      • Decreased PF ratio indicating impaired oxygenation.
      • Exclusion of cardiogenic causes for pulmonary edema.
    • Non-cardiogenic pulmonary edema is established using methods like echocardiograms to assess left ventricular ejection fraction and BNP levels.
    • The Swan-Ganz catheter can measure pulmonary capillary wedge pressure; a reading less than 18 mmHg indicates non-cardiogenic pulmonary edema.

    Treatment of ARDS

    • Treatment is tailored based on the severity of ARDS and the patient's hemodynamic stability.
    • Mild ARDS (PF ratio 200-300) management includes:
      • Non-invasive positive pressure ventilation (NIPPV), such as CPAP or high-flow nasal cannula.
      • If unstable, consider intubation promptly.
    • Moderate to severe ARDS requires immediate intubation regardless of stability, followed by lung protective ventilation strategies.
    • Lung protective strategies aim to minimize further lung injury:
      • Maintain low tidal volume ventilation.
      • Regular assessment of the patient's PF ratio.
    • Additional interventions may include:
      • Proning to improve ventilation and oxygenation.
      • Neuromuscular blockade for asynchrony in breathing.
      • Inhaled nitric oxide or alternative ventilation modes like APRV (airway pressure release ventilation).
    • For COVID-19 related ARDS, corticosteroids such as dexamethasone and antiviral medications like remdesivir may be utilized. Other treatments can include tocilizumab or other immunomodulators.### ARDS Management Overview
    • Extracorporeal Membrane Oxygenation (ECMO) may be considered for refractory cases of Acute Respiratory Distress Syndrome (ARDS).
    • Initial management for mild ARDS includes assessing hemodynamic stability and considering interventions such as non-invasive positive pressure ventilation (NIPPV).

    NIPPV and High Flow Oxygen Delivery

    • NIPPV refers to non-invasive methods to provide positive pressure support; commonly used methods include Optiflow and Vapotherm.
    • High flow nasal cannula (HFNC) can deliver 50-60 liters of oxygen per minute, facilitating dead space washout in the respiratory system, enhancing gas exchange.
    • HFNC helps reduce work of breathing and can provide a small amount of Positive End Expiratory Pressure (PEEP), between 0-5 cm H2O.

    BiPAP Therapy

    • BiPAP (Bilevel Positive Airway Pressure) provides both inspiratory and expiratory pressure assistance, enhancing oxygenation and reducing work of breathing.
    • Inspiratory airway pressure helps in delivering pressure support, while expiratory pressure (PEEP) prevents alveolar collapse during exhalation.
    • While beneficial, BiPAP can lead to secretion buildup or mucus plugging, potentially decreasing oxygen saturation.

    Lung Protective Ventilation

    • Study-driven protocols emphasize lung protective ventilation in ARDS management, utilizing lower tidal volumes of 4-6 cc/kg of ideal body weight.
    • Higher tidal volumes (12 cc/kg) correlate with increased mortality due to risks of barotrauma or volume trauma to open alveoli.
    • Respiratory acidosis may occur with lower tidal volume strategies, necessitating monitoring of carbon dioxide levels (CO2) and pH.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is essential in maintaining open alveoli during ventilation, targeting >5 cm H2O to optimize oxygenation by preventing collapse of fluid-filled or consolidated alveoli.
    • Higher PEEP can improve recruitment of collapsed alveoli, enhancing oxygen transfer to blood.

    Fraction of Inspired Oxygen (FiO2)

    • Aim to keep FiO2 levels ≤60% to avoid hyperoxia while targeting a partial arterial pressure of oxygen (PaO2) between 55-85 mmHg.
    • Monitor SpO2 levels with acceptable ranges typically between 85-95%, with relaxed targets of 88-92% for patient comfort.

    Key Considerations

    • Perpetual monitoring of airway protection is crucial; inability to protect the airway may necessitate intubation.
    • Balance the benefits of protective ventilation strategies against potential complications such as respiratory acidosis, ensuring patient safety throughout the management of ARDS.

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS presents with sudden respiratory failure within a week of an insult, characterized by dyspnea, hypoxemia, and cyanosis.
    • Imaging findings include bilateral opacification, often described as "white out," on chest X-rays.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia is the most common cause, with pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and PJP in immunocompromised patients.
      • Aspiration pneumonia results from acidic gastric content damaging lung tissue.
      • Lung contusions from trauma directly harm lung parenchyma.
      • Near drowning effects vary: freshwater causes surfactant washout, while saltwater induces pulmonary edema.
      • Toxic smoke inhalation can damage alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis leads to cytokine storms, increasing pulmonary capillary permeability and causing fluid leakage into alveoli.
      • Pancreatitis releases enzymes that damage alveolar and capillary endothelial cells.
      • Fat emboli from long bone fractures can produce oleic acid, harming lung structures.
      • Transfusion-Related Acute Lung Injury (TRALI) results from antibodies in transfusions triggering neutrophil activation.
      • Drug toxicity, including cocaine and opioids, poses risks with unclear mechanisms.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes impairs gas exchange and surfactant production.
    • Activated alveolar macrophages produce cytokines (IL-1, IL-6, TNF-alpha), increasing capillary permeability and fluid extravasation.
    • Neutrophil recruitment leads to further damage through the release of reactive oxygen species and proteases.
    • Fluid, debris, and proteins create a hyaline membrane, blocking gas exchange and causing hypoxemia.
    • Reflex responses to hypoxemia include increased respiratory and heart rates, with cyanosis possible.

    Diagnosis of ARDS

    • Berlin Criteria identify ARDS through:

      • Symptoms of acute respiratory failure within one week.
      • Imaging revealing bilateral opacification.
      • Establishing non-cardiogenic pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray serves as the primary diagnostic tool for bilateral opacification.
      • CT scans provide detailed views of lung abnormalities, such as consolidation and edema.
      • Lung ultrasound can quickly indicate pulmonary edema through B lines.

    Clinical Manifestations

    • Key symptoms include severe respiratory distress and crackles due to fluid accumulation in lung spaces.
    • Severe cases may exhibit a “crazy paving” pattern on imaging, indicative of extensive lung consolidation.

    Potential Outcomes

    • Recovery may involve re-epithelialization and lung tissue repair; Type 2 pneumocytes are vital for surfactant production and fluid clearance.
    • Severe cases can lead to fibrotic lung changes, resulting in restrictive lung disease and persistent hypoxemia.

    PF Ratio and ARDS Diagnosis

    • PF ratio calculates oxygenation by dividing arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • Normal PF ratio exceeds 300; lower values signify varying ARDS severity.
      • Mild ARDS: PF ratio 200-300
      • Moderate ARDS: PF ratio 100-200
      • Severe ARDS: PF ratio <100

    Berlin Criteria for ARDS

    • The Berlin criteria specify the diagnosis by confirming bilateral opacities on chest X-ray, decreased PF ratio, and excluding cardiogenic pulmonary edema.
    • Non-cardiogenic causes are verified through echocardiograms assessing left ventricular function and BNP levels; a pulmonary capillary wedge pressure <18 mmHg supports the diagnosis.

    Treatment of ARDS

    • Treatment strategies vary by severity and hemodynamic status:
      • Mild ARDS (PF 200-300): Non-invasive ventilation (NIPPV) like CPAP is preferred; intubation considered if unstable.
      • Moderate/severe ARDS: Intubation is prioritized, followed by lung protective ventilation.
    • Lung protective strategies minimize further injury by maintaining low tidal volume and regularly assessing PF ratios.
    • Additional interventions can include:
      • Proning for improved oxygenation and ventilation.
      • Neuromuscular blockade for synchrony issues.
      • Use of inhaled nitric oxide or alternative modes like APRV.
      • Specific treatments for COVID-19 related ARDS include dexamethasone and remdesivir, with potential use of immunomodulators like tocilizumab.

    ARDS Management Overview

    • Consider Extracorporeal Membrane Oxygenation (ECMO) for refractory ARDS cases.
    • Initial management of mild ARDS involves assessing hemodynamic stability and implementing NIPPV.

    NIPPV and High Flow Oxygen Delivery

    • NIPPV, including methods like Optiflow and Vapotherm, provides positive pressure support without intubation.
    • High flow nasal cannula (HFNC) supplies 50-60 liters of oxygen per minute, optimizing gas exchange and reducing breathing effort.

    BiPAP Therapy

    • BiPAP offers dual pressure assistance for inspiration and expiration, improving oxygenation but risks mucus plugging or secretion buildup.

    Lung Protective Ventilation

    • Protocols emphasize low tidal volume ventilation (4-6 cc/kg ideal body weight) to reduce mortality risks associated with higher volumes.
    • Continuous monitoring of carbon dioxide levels and pH is essential to address potential respiratory acidosis.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is critical for maintaining alveolar integrity during ventilation, aiming for levels >5 cm H2O to enhance oxygenation.

    Fraction of Inspired Oxygen (FiO2)

    • FiO2 should be maintained at ≤60% to prevent hyperoxia; target PaO2 levels are 55-85 mmHg with SpO2 between 85-95%.

    Key Considerations

    • Persistent airway protection monitoring is essential; limitations may necessitate intubation.
    • Weigh the advantages of protective ventilation against complications, prioritizing patient safety in ARDS management.

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS presents with sudden respiratory failure within a week of an insult, characterized by dyspnea, hypoxemia, and cyanosis.
    • Imaging findings include bilateral opacification, often described as "white out," on chest X-rays.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia is the most common cause, with pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and PJP in immunocompromised patients.
      • Aspiration pneumonia results from acidic gastric content damaging lung tissue.
      • Lung contusions from trauma directly harm lung parenchyma.
      • Near drowning effects vary: freshwater causes surfactant washout, while saltwater induces pulmonary edema.
      • Toxic smoke inhalation can damage alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis leads to cytokine storms, increasing pulmonary capillary permeability and causing fluid leakage into alveoli.
      • Pancreatitis releases enzymes that damage alveolar and capillary endothelial cells.
      • Fat emboli from long bone fractures can produce oleic acid, harming lung structures.
      • Transfusion-Related Acute Lung Injury (TRALI) results from antibodies in transfusions triggering neutrophil activation.
      • Drug toxicity, including cocaine and opioids, poses risks with unclear mechanisms.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes impairs gas exchange and surfactant production.
    • Activated alveolar macrophages produce cytokines (IL-1, IL-6, TNF-alpha), increasing capillary permeability and fluid extravasation.
    • Neutrophil recruitment leads to further damage through the release of reactive oxygen species and proteases.
    • Fluid, debris, and proteins create a hyaline membrane, blocking gas exchange and causing hypoxemia.
    • Reflex responses to hypoxemia include increased respiratory and heart rates, with cyanosis possible.

    Diagnosis of ARDS

    • Berlin Criteria identify ARDS through:

      • Symptoms of acute respiratory failure within one week.
      • Imaging revealing bilateral opacification.
      • Establishing non-cardiogenic pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray serves as the primary diagnostic tool for bilateral opacification.
      • CT scans provide detailed views of lung abnormalities, such as consolidation and edema.
      • Lung ultrasound can quickly indicate pulmonary edema through B lines.

    Clinical Manifestations

    • Key symptoms include severe respiratory distress and crackles due to fluid accumulation in lung spaces.
    • Severe cases may exhibit a “crazy paving” pattern on imaging, indicative of extensive lung consolidation.

    Potential Outcomes

    • Recovery may involve re-epithelialization and lung tissue repair; Type 2 pneumocytes are vital for surfactant production and fluid clearance.
    • Severe cases can lead to fibrotic lung changes, resulting in restrictive lung disease and persistent hypoxemia.

    PF Ratio and ARDS Diagnosis

    • PF ratio calculates oxygenation by dividing arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • Normal PF ratio exceeds 300; lower values signify varying ARDS severity.
      • Mild ARDS: PF ratio 200-300
      • Moderate ARDS: PF ratio 100-200
      • Severe ARDS: PF ratio <100

    Berlin Criteria for ARDS

    • The Berlin criteria specify the diagnosis by confirming bilateral opacities on chest X-ray, decreased PF ratio, and excluding cardiogenic pulmonary edema.
    • Non-cardiogenic causes are verified through echocardiograms assessing left ventricular function and BNP levels; a pulmonary capillary wedge pressure <18 mmHg supports the diagnosis.

    Treatment of ARDS

    • Treatment strategies vary by severity and hemodynamic status:
      • Mild ARDS (PF 200-300): Non-invasive ventilation (NIPPV) like CPAP is preferred; intubation considered if unstable.
      • Moderate/severe ARDS: Intubation is prioritized, followed by lung protective ventilation.
    • Lung protective strategies minimize further injury by maintaining low tidal volume and regularly assessing PF ratios.
    • Additional interventions can include:
      • Proning for improved oxygenation and ventilation.
      • Neuromuscular blockade for synchrony issues.
      • Use of inhaled nitric oxide or alternative modes like APRV.
      • Specific treatments for COVID-19 related ARDS include dexamethasone and remdesivir, with potential use of immunomodulators like tocilizumab.

    ARDS Management Overview

    • Consider Extracorporeal Membrane Oxygenation (ECMO) for refractory ARDS cases.
    • Initial management of mild ARDS involves assessing hemodynamic stability and implementing NIPPV.

    NIPPV and High Flow Oxygen Delivery

    • NIPPV, including methods like Optiflow and Vapotherm, provides positive pressure support without intubation.
    • High flow nasal cannula (HFNC) supplies 50-60 liters of oxygen per minute, optimizing gas exchange and reducing breathing effort.

    BiPAP Therapy

    • BiPAP offers dual pressure assistance for inspiration and expiration, improving oxygenation but risks mucus plugging or secretion buildup.

    Lung Protective Ventilation

    • Protocols emphasize low tidal volume ventilation (4-6 cc/kg ideal body weight) to reduce mortality risks associated with higher volumes.
    • Continuous monitoring of carbon dioxide levels and pH is essential to address potential respiratory acidosis.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is critical for maintaining alveolar integrity during ventilation, aiming for levels >5 cm H2O to enhance oxygenation.

    Fraction of Inspired Oxygen (FiO2)

    • FiO2 should be maintained at ≤60% to prevent hyperoxia; target PaO2 levels are 55-85 mmHg with SpO2 between 85-95%.

    Key Considerations

    • Persistent airway protection monitoring is essential; limitations may necessitate intubation.
    • Weigh the advantages of protective ventilation against complications, prioritizing patient safety in ARDS management.

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS presents with sudden respiratory failure within a week of an insult, characterized by dyspnea, hypoxemia, and cyanosis.
    • Imaging findings include bilateral opacification, often described as "white out," on chest X-rays.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia is the most common cause, with pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and PJP in immunocompromised patients.
      • Aspiration pneumonia results from acidic gastric content damaging lung tissue.
      • Lung contusions from trauma directly harm lung parenchyma.
      • Near drowning effects vary: freshwater causes surfactant washout, while saltwater induces pulmonary edema.
      • Toxic smoke inhalation can damage alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis leads to cytokine storms, increasing pulmonary capillary permeability and causing fluid leakage into alveoli.
      • Pancreatitis releases enzymes that damage alveolar and capillary endothelial cells.
      • Fat emboli from long bone fractures can produce oleic acid, harming lung structures.
      • Transfusion-Related Acute Lung Injury (TRALI) results from antibodies in transfusions triggering neutrophil activation.
      • Drug toxicity, including cocaine and opioids, poses risks with unclear mechanisms.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes impairs gas exchange and surfactant production.
    • Activated alveolar macrophages produce cytokines (IL-1, IL-6, TNF-alpha), increasing capillary permeability and fluid extravasation.
    • Neutrophil recruitment leads to further damage through the release of reactive oxygen species and proteases.
    • Fluid, debris, and proteins create a hyaline membrane, blocking gas exchange and causing hypoxemia.
    • Reflex responses to hypoxemia include increased respiratory and heart rates, with cyanosis possible.

    Diagnosis of ARDS

    • Berlin Criteria identify ARDS through:

      • Symptoms of acute respiratory failure within one week.
      • Imaging revealing bilateral opacification.
      • Establishing non-cardiogenic pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray serves as the primary diagnostic tool for bilateral opacification.
      • CT scans provide detailed views of lung abnormalities, such as consolidation and edema.
      • Lung ultrasound can quickly indicate pulmonary edema through B lines.

    Clinical Manifestations

    • Key symptoms include severe respiratory distress and crackles due to fluid accumulation in lung spaces.
    • Severe cases may exhibit a “crazy paving” pattern on imaging, indicative of extensive lung consolidation.

    Potential Outcomes

    • Recovery may involve re-epithelialization and lung tissue repair; Type 2 pneumocytes are vital for surfactant production and fluid clearance.
    • Severe cases can lead to fibrotic lung changes, resulting in restrictive lung disease and persistent hypoxemia.

    PF Ratio and ARDS Diagnosis

    • PF ratio calculates oxygenation by dividing arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • Normal PF ratio exceeds 300; lower values signify varying ARDS severity.
      • Mild ARDS: PF ratio 200-300
      • Moderate ARDS: PF ratio 100-200
      • Severe ARDS: PF ratio <100

    Berlin Criteria for ARDS

    • The Berlin criteria specify the diagnosis by confirming bilateral opacities on chest X-ray, decreased PF ratio, and excluding cardiogenic pulmonary edema.
    • Non-cardiogenic causes are verified through echocardiograms assessing left ventricular function and BNP levels; a pulmonary capillary wedge pressure <18 mmHg supports the diagnosis.

    Treatment of ARDS

    • Treatment strategies vary by severity and hemodynamic status:
      • Mild ARDS (PF 200-300): Non-invasive ventilation (NIPPV) like CPAP is preferred; intubation considered if unstable.
      • Moderate/severe ARDS: Intubation is prioritized, followed by lung protective ventilation.
    • Lung protective strategies minimize further injury by maintaining low tidal volume and regularly assessing PF ratios.
    • Additional interventions can include:
      • Proning for improved oxygenation and ventilation.
      • Neuromuscular blockade for synchrony issues.
      • Use of inhaled nitric oxide or alternative modes like APRV.
      • Specific treatments for COVID-19 related ARDS include dexamethasone and remdesivir, with potential use of immunomodulators like tocilizumab.

    ARDS Management Overview

    • Consider Extracorporeal Membrane Oxygenation (ECMO) for refractory ARDS cases.
    • Initial management of mild ARDS involves assessing hemodynamic stability and implementing NIPPV.

    NIPPV and High Flow Oxygen Delivery

    • NIPPV, including methods like Optiflow and Vapotherm, provides positive pressure support without intubation.
    • High flow nasal cannula (HFNC) supplies 50-60 liters of oxygen per minute, optimizing gas exchange and reducing breathing effort.

    BiPAP Therapy

    • BiPAP offers dual pressure assistance for inspiration and expiration, improving oxygenation but risks mucus plugging or secretion buildup.

    Lung Protective Ventilation

    • Protocols emphasize low tidal volume ventilation (4-6 cc/kg ideal body weight) to reduce mortality risks associated with higher volumes.
    • Continuous monitoring of carbon dioxide levels and pH is essential to address potential respiratory acidosis.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is critical for maintaining alveolar integrity during ventilation, aiming for levels >5 cm H2O to enhance oxygenation.

    Fraction of Inspired Oxygen (FiO2)

    • FiO2 should be maintained at ≤60% to prevent hyperoxia; target PaO2 levels are 55-85 mmHg with SpO2 between 85-95%.

    Key Considerations

    • Persistent airway protection monitoring is essential; limitations may necessitate intubation.
    • Weigh the advantages of protective ventilation against complications, prioritizing patient safety in ARDS management.

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS presents with sudden respiratory failure within a week of an insult, characterized by dyspnea, hypoxemia, and cyanosis.
    • Imaging findings include bilateral opacification, often described as "white out," on chest X-rays.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia is the most common cause, with pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and PJP in immunocompromised patients.
      • Aspiration pneumonia results from acidic gastric content damaging lung tissue.
      • Lung contusions from trauma directly harm lung parenchyma.
      • Near drowning effects vary: freshwater causes surfactant washout, while saltwater induces pulmonary edema.
      • Toxic smoke inhalation can damage alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis leads to cytokine storms, increasing pulmonary capillary permeability and causing fluid leakage into alveoli.
      • Pancreatitis releases enzymes that damage alveolar and capillary endothelial cells.
      • Fat emboli from long bone fractures can produce oleic acid, harming lung structures.
      • Transfusion-Related Acute Lung Injury (TRALI) results from antibodies in transfusions triggering neutrophil activation.
      • Drug toxicity, including cocaine and opioids, poses risks with unclear mechanisms.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes impairs gas exchange and surfactant production.
    • Activated alveolar macrophages produce cytokines (IL-1, IL-6, TNF-alpha), increasing capillary permeability and fluid extravasation.
    • Neutrophil recruitment leads to further damage through the release of reactive oxygen species and proteases.
    • Fluid, debris, and proteins create a hyaline membrane, blocking gas exchange and causing hypoxemia.
    • Reflex responses to hypoxemia include increased respiratory and heart rates, with cyanosis possible.

    Diagnosis of ARDS

    • Berlin Criteria identify ARDS through:

      • Symptoms of acute respiratory failure within one week.
      • Imaging revealing bilateral opacification.
      • Establishing non-cardiogenic pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray serves as the primary diagnostic tool for bilateral opacification.
      • CT scans provide detailed views of lung abnormalities, such as consolidation and edema.
      • Lung ultrasound can quickly indicate pulmonary edema through B lines.

    Clinical Manifestations

    • Key symptoms include severe respiratory distress and crackles due to fluid accumulation in lung spaces.
    • Severe cases may exhibit a “crazy paving” pattern on imaging, indicative of extensive lung consolidation.

    Potential Outcomes

    • Recovery may involve re-epithelialization and lung tissue repair; Type 2 pneumocytes are vital for surfactant production and fluid clearance.
    • Severe cases can lead to fibrotic lung changes, resulting in restrictive lung disease and persistent hypoxemia.

    PF Ratio and ARDS Diagnosis

    • PF ratio calculates oxygenation by dividing arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • Normal PF ratio exceeds 300; lower values signify varying ARDS severity.
      • Mild ARDS: PF ratio 200-300
      • Moderate ARDS: PF ratio 100-200
      • Severe ARDS: PF ratio <100

    Berlin Criteria for ARDS

    • The Berlin criteria specify the diagnosis by confirming bilateral opacities on chest X-ray, decreased PF ratio, and excluding cardiogenic pulmonary edema.
    • Non-cardiogenic causes are verified through echocardiograms assessing left ventricular function and BNP levels; a pulmonary capillary wedge pressure <18 mmHg supports the diagnosis.

    Treatment of ARDS

    • Treatment strategies vary by severity and hemodynamic status:
      • Mild ARDS (PF 200-300): Non-invasive ventilation (NIPPV) like CPAP is preferred; intubation considered if unstable.
      • Moderate/severe ARDS: Intubation is prioritized, followed by lung protective ventilation.
    • Lung protective strategies minimize further injury by maintaining low tidal volume and regularly assessing PF ratios.
    • Additional interventions can include:
      • Proning for improved oxygenation and ventilation.
      • Neuromuscular blockade for synchrony issues.
      • Use of inhaled nitric oxide or alternative modes like APRV.
      • Specific treatments for COVID-19 related ARDS include dexamethasone and remdesivir, with potential use of immunomodulators like tocilizumab.

    ARDS Management Overview

    • Consider Extracorporeal Membrane Oxygenation (ECMO) for refractory ARDS cases.
    • Initial management of mild ARDS involves assessing hemodynamic stability and implementing NIPPV.

    NIPPV and High Flow Oxygen Delivery

    • NIPPV, including methods like Optiflow and Vapotherm, provides positive pressure support without intubation.
    • High flow nasal cannula (HFNC) supplies 50-60 liters of oxygen per minute, optimizing gas exchange and reducing breathing effort.

    BiPAP Therapy

    • BiPAP offers dual pressure assistance for inspiration and expiration, improving oxygenation but risks mucus plugging or secretion buildup.

    Lung Protective Ventilation

    • Protocols emphasize low tidal volume ventilation (4-6 cc/kg ideal body weight) to reduce mortality risks associated with higher volumes.
    • Continuous monitoring of carbon dioxide levels and pH is essential to address potential respiratory acidosis.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is critical for maintaining alveolar integrity during ventilation, aiming for levels >5 cm H2O to enhance oxygenation.

    Fraction of Inspired Oxygen (FiO2)

    • FiO2 should be maintained at ≤60% to prevent hyperoxia; target PaO2 levels are 55-85 mmHg with SpO2 between 85-95%.

    Key Considerations

    • Persistent airway protection monitoring is essential; limitations may necessitate intubation.
    • Weigh the advantages of protective ventilation against complications, prioritizing patient safety in ARDS management.

    Acute Respiratory Distress Syndrome (ARDS)

    • ARDS presents with sudden respiratory failure within a week of an insult, characterized by dyspnea, hypoxemia, and cyanosis.
    • Imaging findings include bilateral opacification, often described as "white out," on chest X-rays.

    Causes of ARDS

    • Direct Lung Injuries:

      • Pneumonia is the most common cause, with pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and PJP in immunocompromised patients.
      • Aspiration pneumonia results from acidic gastric content damaging lung tissue.
      • Lung contusions from trauma directly harm lung parenchyma.
      • Near drowning effects vary: freshwater causes surfactant washout, while saltwater induces pulmonary edema.
      • Toxic smoke inhalation can damage alveolar cells.

    • Indirect Lung Injuries:

      • Sepsis leads to cytokine storms, increasing pulmonary capillary permeability and causing fluid leakage into alveoli.
      • Pancreatitis releases enzymes that damage alveolar and capillary endothelial cells.
      • Fat emboli from long bone fractures can produce oleic acid, harming lung structures.
      • Transfusion-Related Acute Lung Injury (TRALI) results from antibodies in transfusions triggering neutrophil activation.
      • Drug toxicity, including cocaine and opioids, poses risks with unclear mechanisms.

    Pathophysiology of ARDS

    • Injury to Type 1 and Type 2 pneumocytes impairs gas exchange and surfactant production.
    • Activated alveolar macrophages produce cytokines (IL-1, IL-6, TNF-alpha), increasing capillary permeability and fluid extravasation.
    • Neutrophil recruitment leads to further damage through the release of reactive oxygen species and proteases.
    • Fluid, debris, and proteins create a hyaline membrane, blocking gas exchange and causing hypoxemia.
    • Reflex responses to hypoxemia include increased respiratory and heart rates, with cyanosis possible.

    Diagnosis of ARDS

    • Berlin Criteria identify ARDS through:

      • Symptoms of acute respiratory failure within one week.
      • Imaging revealing bilateral opacification.
      • Establishing non-cardiogenic pulmonary edema.

    • Imaging Techniques:

      • Chest X-ray serves as the primary diagnostic tool for bilateral opacification.
      • CT scans provide detailed views of lung abnormalities, such as consolidation and edema.
      • Lung ultrasound can quickly indicate pulmonary edema through B lines.

    Clinical Manifestations

    • Key symptoms include severe respiratory distress and crackles due to fluid accumulation in lung spaces.
    • Severe cases may exhibit a “crazy paving” pattern on imaging, indicative of extensive lung consolidation.

    Potential Outcomes

    • Recovery may involve re-epithelialization and lung tissue repair; Type 2 pneumocytes are vital for surfactant production and fluid clearance.
    • Severe cases can lead to fibrotic lung changes, resulting in restrictive lung disease and persistent hypoxemia.

    PF Ratio and ARDS Diagnosis

    • PF ratio calculates oxygenation by dividing arterial partial pressure of oxygen (PaO2) by the fraction of inspired oxygen (FiO2).
    • Normal PF ratio exceeds 300; lower values signify varying ARDS severity.
      • Mild ARDS: PF ratio 200-300
      • Moderate ARDS: PF ratio 100-200
      • Severe ARDS: PF ratio <100

    Berlin Criteria for ARDS

    • The Berlin criteria specify the diagnosis by confirming bilateral opacities on chest X-ray, decreased PF ratio, and excluding cardiogenic pulmonary edema.
    • Non-cardiogenic causes are verified through echocardiograms assessing left ventricular function and BNP levels; a pulmonary capillary wedge pressure <18 mmHg supports the diagnosis.

    Treatment of ARDS

    • Treatment strategies vary by severity and hemodynamic status:
      • Mild ARDS (PF 200-300): Non-invasive ventilation (NIPPV) like CPAP is preferred; intubation considered if unstable.
      • Moderate/severe ARDS: Intubation is prioritized, followed by lung protective ventilation.
    • Lung protective strategies minimize further injury by maintaining low tidal volume and regularly assessing PF ratios.
    • Additional interventions can include:
      • Proning for improved oxygenation and ventilation.
      • Neuromuscular blockade for synchrony issues.
      • Use of inhaled nitric oxide or alternative modes like APRV.
      • Specific treatments for COVID-19 related ARDS include dexamethasone and remdesivir, with potential use of immunomodulators like tocilizumab.

    ARDS Management Overview

    • Consider Extracorporeal Membrane Oxygenation (ECMO) for refractory ARDS cases.
    • Initial management of mild ARDS involves assessing hemodynamic stability and implementing NIPPV.

    NIPPV and High Flow Oxygen Delivery

    • NIPPV, including methods like Optiflow and Vapotherm, provides positive pressure support without intubation.
    • High flow nasal cannula (HFNC) supplies 50-60 liters of oxygen per minute, optimizing gas exchange and reducing breathing effort.

    BiPAP Therapy

    • BiPAP offers dual pressure assistance for inspiration and expiration, improving oxygenation but risks mucus plugging or secretion buildup.

    Lung Protective Ventilation

    • Protocols emphasize low tidal volume ventilation (4-6 cc/kg ideal body weight) to reduce mortality risks associated with higher volumes.
    • Continuous monitoring of carbon dioxide levels and pH is essential to address potential respiratory acidosis.

    Positive End Expiratory Pressure (PEEP)

    • PEEP is critical for maintaining alveolar integrity during ventilation, aiming for levels >5 cm H2O to enhance oxygenation.

    Fraction of Inspired Oxygen (FiO2)

    • FiO2 should be maintained at ≤60% to prevent hyperoxia; target PaO2 levels are 55-85 mmHg with SpO2 between 85-95%.

    Key Considerations

    • Persistent airway protection monitoring is essential; limitations may necessitate intubation.
    • Weigh the advantages of protective ventilation against complications, prioritizing patient safety in ARDS management.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz explores the characteristics, causes, and imaging findings associated with Acute Respiratory Distress Syndrome (ARDS). Participants will learn about direct and indirect lung injuries that contribute to ARDS, including pneumonia, aspiration, and trauma. Test your knowledge on this critical respiratory condition.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser